Skip to main content
. 2014 Jan 27;9(1):e86215. doi: 10.1371/journal.pone.0086215

Table 9. Factors associated with occurrence of drug use problems, drug interactions and other problems.

Factors Drug use problems (n = 20) Drug interactions (n = 97) Other problems (n = 11)
Yes No p-value Yes No p-value Yes No p-value
Elderly
Yes 16 (80.0) 193 (80.8) 1.000b 77 (79.4) 132 (81.5) 0.801a 10 (90.9) 199 (80.2) 0.696b
No 4 (20.0) 46 (19.2) 20 (20.6) 30 (18.5) 1 (9.1) 49 (19.8)
Duration of hospitalization
Yes 7 (35.0) 82 (34.3) 1.000a 40 (41.2) 49 (30.2) 0.095a 5 (45.5) 84 (33.9) 0.519b
No 13 (65.0) 157 (65.7) 57 (58.8) 113 (69.8) 6 (54.5) 164 (66.1)
Polypharmacy
Yes 15 (75.0) 177 (74.1) 1.000a 87 (89.7) 105 (64.8) <0.001a * 8 (72.7) 184 (74.2) 1.000b
No 5 (25.0) 62 (25.9) 10 (10.3) 57 (35.2) 3 (27.3) 64 (25.8)
Multiple comorbidities
Yes 17 (85.0) 210 (87.9) 0.722b 96 (99.0) 131 (80.9) <0.001a * 8 (72.7) 219 (88.3) 0.142b
No 3 (15.0) 29 (12.1) 1 (1.0) 31 (19.1) 3 (27.3) 29 (11.7)
Cardiovascular disease
Yes 8 (40.0) 69 (28.9) 0.429a 41 (42.3) 36 (22.2) 0.001a * 3 (27.3) 74 (29.8) 1.000b
No 12 (60.0) 170 (71.1) 56 (57.7) 126 (77.8) 8 (72.7) 174 (70.2)
Diabetes mellitus
Yes 12 (60.0) 104 (43.5) 0.234a 52 (53.6) 64 (39.5) 0.038a * 5 (45.5) 111 (44.8) 1.000b
No 8 (40.0) 135 (56.5) 45 (46.4) 98 (60.5) 6 (54.5) 137 (55.2)
Hypertension
Yes 14 (70.0) 163 (68.2) 1.000a 89 (91.8) 88 (54.3) <0.001a * 8 (72.7) 169 (68.1) 1.000b
No 6 (30.0) 76 (31.8) 8 (8.2) 74 (45.7) 3 (27.3) 79 (31.9)
Renal impairment
Yes 2 (10.0) 45 (18.8) 0.545b 21 (21.6) 26 (16.0) 0.334 3 (27.3) 44 (17.7) 0.425
No 18 (90.0) 194 (81.2) 76 (78.4) 136 (84.0) 8 (72.7) 204 (82.3)
a

Computed using Continuity Correction;

b

Computed using Fisher's Exact Test;

*

Statistically significant (p<0.05).